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Abstract Incubation of hepatocytes under hypoxia increases
binding of translation initiation factor eIF-4E to its inhibitory
regulator 4E-BP1, and this correlates with dephosphorylation of
4E-BP1. Rapamycin induced the same effect in aerobic cells but
no additive effect was observed when hypoxic cells were treated
with rapamycin. This enhanced association of 4E-BP1 with eIF-
4E might be mediated by mTOR. Nevertheless, only hypoxia
produces a rapid inhibition of protein synthesis. Although
hypoxia might be signalling via the rapamycin-sensitive pathway
by changing eIF-4E availability, such a pathway is unlikely to be
responsible for the depression in overall protein synthesis under
hypoxia.
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1. Introduction
Phosphorylation/dephosphorylation of translation factors
plays a key role in the control of protein synthesis that is
exerted mainly at the level of initiation [1]. The 5Pcap structure
of eukaryotic mRNA facilitates its binding to the 40S riboso-
mal subunit. This rate-limiting step is mediated by eukaryotic
initiation factor 4F (eIF-4F) which consists of three proteins:
the cap-binding protein eIF-4E, the RNA helicase eIF-4A,
and eIF-4G, a sca¡olding protein for the assembly of the
ribosomal initiation complex [1^4]. Three related eIF-4E-bind-
ing proteins (4E-BPs) are currently involved in the regulation
of eIF-4F formation [3]. In the dephosphorylated form, 4E-
BPs bind to eIF-4E and competitively inhibit its association
with eIF-4G [3,4]. This prevents eIF-4F formation and im-
pairs cap-dependent translation [3^7]. Numerous stimuli in£u-
ence the phosphorylation state of 4E-BP1 (also termed phos-
phoprotein heat- and acid-stable induced by insulin, PHAS-I).
Dephosphorylation has been reported in culture cells in re-
sponse to heat shock, virus infection or amino acid depriva-
tion [2,8^11]. By contrast, growth factors and hormones stim-
ulate the phosphorylation of 4E-BP1 and consequently
facilitate eIF-4F formation [2,3,12]. These events have been
implicated in the insulin-mediated stimulation of protein syn-
thesis [5,13]. A rapamycin-sensitive signal transduction path-
way, also termed mTOR pathway referring to the target pro-
tein of rapamycin action, appears to play a key role in the
regulation of 4E-BP1 phosphorylation in response to hor-
mones, growth factors and amino acids [3,7,8,14^16].
Although reduced O2 tension has been reported to induce
the expression of speci¢c genes [17], it is well established that
preservation of mammalian cells under low oxygen pressure
leads to a severe inhibition of mRNA translation [18]. We
have previously reported that incubation of isolated rat hep-
atocytes under low pO2 causes a fast and reversible inhibition
of total protein synthesis which precedes the depletion of
ATP. This inhibition was not related to enhanced proteolytic
activities, to a reduced amino acid uptake or to the appear-
ance of speci¢c stress proteins [19,20].
The phosphorylation state of 4E-BP1 and its ability to reg-
ulate eIF-4E availability appear to play an important role in
the regulation of mRNA translation in eukaryotic cells. In the
present study, we therefore investigated whether these events
mediate the inhibition of total protein synthesis induced by
hypoxia in isolated rat hepatocytes.
2. Materials and methods
2.1. Preparation and incubation of hepatocytes
Hepatocytes were isolated as described previously [20] from fed
male Wistar rats (260^280 g). The hepatocytes (2U106 cells/ml)
were incubated at 37‡C under a continuous £ow of either O2/CO2
(95:5%; 700 mm Hg O2 ; control) or O2/N2/CO2 (5:90:5%; 50 mm
Hg O2 ; hypoxia) in Dulbecco’s modi¢ed Eagle’s medium (DMEM)
supplemented with 0.3% (w/v) BSA. Cell viability was checked by
measuring the released activity of lactate dehydrogenase as described
elsewhere [21].
2.2. Preparation of cell extract
Cells were collected by centrifugation, washed with ice-cold phos-
phate-bu¡ered saline and homogenized by sonication as described
elsewhere [14] in bu¡er A composed of 50 mM Tris-HCl (pH 7.5),
50 mM L-glycerophosphate, 1.5 mM EGTA, 1 mM benzamidine,
1 mM dithiothreitol, 0.5 mM Na3VO4, 0.1 mM PMSF, 1 WM micro-
cystin-LR, 1 Wg/ml of each pepstatin, antipain and leupeptin. Homo-
genates were centrifuged at 10 000Ug for 20 min at 4‡C and the
supernatants were removed and frozen at 380‡C. To detect 4E-
BP1, normalized amounts of proteins were boiled for 5 min and
centrifuged at 10 000Ug for 30 min as described elsewhere [6]. The
resulting heat-stable proteins were dissolved in SDS sample bu¡er and
processed for SDS-PAGE and Western blotting.
2.3. Immunoblot analysis
Proteins were separated by SDS-PAGE in 15% (w/v) acrylamide
resolving gels [22] and electrophoretically transferred to polyvinyli-
dene membranes using a semi-dry transfer cell. The membranes
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were blocked for 45 min in TBS (20 mM Tris-HCl, pH 7.6, 137 mM
NaCl) containing 0.05% (v/v) Tween 20 and 5% (w/v) defatted milk
and incubated overnight with anti 4E-BP1 (0.4 Wg/ml in blocking
bu¡er). The membranes were washed ¢ve times in TBS/0.1% Tween
20 prior to incubation with horseradish peroxidase-conjugated anti-
goat IgG (1:7000) diluted in blocking bu¡er. Both ¢rst and secondary
antibody were purchased from Santa Cruz Biotechnology. After
washing as described above, the membranes were rinsed in TBS and
the immunoreactive bands were detected by using the ECL kit from
Amersham.
2.4. eIF-4E/4E-BP1 binding assay
The ability of 4E-BP1 to bind with eIF-4E was determined after
recovering of eIF-4E by 7-methylguanosine triphosphate (m7GTP)-
Sepharose CL-4B (Pharmacia Biotech) chromatography using a modi-
¢ed protocol described elsewhere [6,16]. Brie£y, cell extracts were
tumbled with m7GTP-Sepharose for 60 min at 4‡C. The beads were
pelleted by brief centrifugation and washed three times with bu¡er A.
Proteins were eluted by boiling the pelleted beads in SDS sample
bu¡er and subjected to SDS-PAGE and immunoblotting with anti-
4E-BP1 antibody and anti-eIF-4E antiserum (diluted 1/1000) as de-
scribed above. The membranes were sequentially incubated with
horseradish peroxidase-conjugated anti-goat and anti-rabbit IgG
and the proteins were visualized by chemiluminescence detection.
2.5. Assays
Protein synthesis was estimated by measuring the incorporation of
[14C]Leu (Amersham, speci¢c activity 94 mCi/mmol, 0.8 mM unla-
belled Leu) into the pelleted material obtained by perchloric acid
precipitation as described elsewhere [23]. Results were expressed as
pmol Leu incorporated/mg protein. The amount of protein was de-
termined by the Lowry method, using BSA as standard [24].
2.6. Statistics
Results are expressed as mean values þ S.E.M. of at least three
separate experiments. Analysis of variance (two-way ANOVA with
the interaction time/treatment) was used to compare the concentra-
tion-response curves. A P value less than 0.05 was set as the minimum
level of signi¢cance.
3. Results
3.1. E¡ect of hypoxia on 4E-BP1 phosphorylation
4E-BP1 from various tissues appears as three migrating
bands (K^Q) when subjected to SDS-PAGE electrophoresis
and immunoblot analysis [5,6,10^16]. These bands correspond
to di¡erent phosphorylation states of 4E-BP1, ranging from a
fast-migrating dephosphorylated form (K) to a slow-migrating
hyperphosphorylated form (Q). When isolated hepatocytes are
incubated under control conditions, the three species of 4E-
BP1 are resolved on SDS-PAGE (Fig. 1). In these cells, the
phosphorylated forms L and Q are predominant whereas the
non-phosphorylated form is barely detectable. Incubation of
cells under hypoxia causes a shift in the electrophoretic pat-
tern of 4E-BP1 which is indicative of increased dephosphoryl-
ation of the protein. Indeed, the slow-migrating Q form virtu-
ally disappeared whereas the non-phosphorylated K form
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Fig. 1. E¡ect of hypoxia on the phosphorylation of 4E-BP1 in isolated rat hepatocytes. Cells were incubated in DMEM under either control
(700 mm Hg O2) or hypoxic (50 mm Hg O2) conditions. At the times indicated, aliquots of cell suspension were collected. Cell extracts were
prepared as described in Section 2 and normalized amount of proteins were boiled for 5 min. The heat-soluble proteins were further processed
for immunoblotting using anti-4E-BP1 antibody as described in Section 2. Results are representative of three independent experiments.
Fig. 2. A and B: Times course association of 4E-BP1 to eIF-4E in
response to hypoxia. Cells were incubated in DMEM under either
control or hypoxic conditions as described in the legend to Fig. 1.
At the times indicated, aliquots of cell suspension were collected
and cell extracts were prepared as described in Section 2. Equal pro-
tein amounts were further subjected to m7GTP-Sepharose chroma-
tography and the retained fractions were processed for immunoblot-
ting using anti-4E-BP1 antibody and anti-eIF-4E antiserum as
described in the Section 2. Results are representative of three inde-
pendent experiments. *P6 0.05 compared to aerobic control condi-
tions. **No signi¢cant e¡ect compared to control conditions.
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became apparent and was maintained for up to 90 min after
the onset of hypoxia.
3.2. Hypoxia increases the association of 4E-BP1 to eIF-4E
Only the two fast-migrating forms of 4E-BP1 have been
reported in various other cell types to form a complex with
the cap-binding protein eIF-4E [6,10,13,25,26]. This has led us
to investigate the e¡ect of hypoxia on the amount of 4E-BP1
recovered when eIF-4E was partially puri¢ed with the mRNA
cap a⁄nity resin m7GTP-Sepharose. In control hepatocytes,
the amount of 4E-BP1 associated with eIF-4E remains quite
constant and only the K and L forms of the protein are re-
solved by immunoblot analysis (Fig. 2A). Consistent with
data reported for other cells types, our results indicate that
the hyperphosphorylated form of 4E-BP1 present in isolated
hepatocytes does not bind to the translation initiation factor
eIF-4E. Compared to control cells, incubation of hepatocytes
under low oxygen pressure leads to a fast increase in the
amount of 4E-BP1 forms (K, L) associated with eIF-4E (Fig.
2A,B). Hypoxia does not, however, a¡ect the amount of eIF-
4E bound to the a⁄nity resin which remains similar to that
recovered from control hepatocytes. These results thus indi-
cate that hypoxia stimulates the dephosphorylation of 4E-BP1
and consequently induces its association with eIF-4E.
3.3. E¡ect of rapamycin on the hypoxia-mediated cell response
Recent data support a major role of the mTOR (mamma-
lian target of rapamycin) signalling pathway in the regulation
of 4E-BP1 phosphorylation in response to stimuli such as
growth factors, hormones and amino acid de¢ciency [15,27^
31]. We therefore investigated the e¡ect of rapamycin on the
synthesis of proteins as well as on the ability of 4E-BP1 to
bind to eIF-4E in hepatocytes maintained under di¡erent pO2
levels. Fig. 3 shows that addition of rapamycin to hepatocytes
incubated under O2/CO2 (700 mm Hg O2) induced the de-
phosphorylation of 4E-BP1 (Fig. 3A) and increased the
amount of 4E-BP1 bound to eIF-4E, as compared to un-
treated cells (Fig. 3B). These rapamycin-mediated events
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Fig. 3. E¡ect of rapamycin on the dephosphorylation of 4E-BP1 (A, C) and on the enhanced association of 4E-BP1 with eIF-4E (B, D) in-
duced by hypoxia. Cells were incubated for 30 or 45 min in DMEM under either control (700 mm Hg O2) or hypoxic (50 mm Hg O2) condi-
tions in the absence or presence of rapamycin 500 nM. Cell extracts were prepared as described in Section 2. A: Heat-soluble proteins of total
cell extracts were subjected to immunoblotting using anti-4E-BP1 antibody. B: Cell extracts were subjected to a⁄nity chromatography on
m7GTP-Sepharose, followed by immunoblotting using anti-4E-BP1 antibody and anti-eIF-4E antiserum as described in Section 2. Summary
data of these blots are graphed in C (dephosphorylation of 4E-BP1 by rapamycin) and D (association of 4E-BP1 with eIF-4E). *P6 0.05 com-
pared to control (aerobic and no addition) conditions.
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were similar to that induced by hypoxia alone and no additive
e¡ect was observed when hypoxic cells were treated with ra-
pamycin (Fig. 3C,D).
Although both hypoxia and rapamycin increase the associ-
ation of 4E-BP1 with eIF-4E, only incubation of hepatocytes
under low oxygen pressure causes a strong inhibition of the
synthesis of proteins (Fig. 4). Compared to control hepato-
cytes, the incorporation of [14C]leucine was reduced by 70%
and 85% when cells were kept for 15 min and 60 min, respec-
tively, under hypoxia. This rapid protein synthesis inhibition
occurred prior to signi¢cant release of lactate dehydrogenase
in the culture medium and was therefore unlikely to be related
to cell death (data not shown). As shown in Fig. 4, rapamycin
by itself does not a¡ect the synthesis of protein whether cells
were incubated under control or hypoxic conditions as com-
pared to the corresponding untreated cell populations.
4. Discussion
Binding of mRNA to the 40S ribosomal subunit represents
one of the key steps in translation in higher eukaryotic cells
[1^4]. This process is mediated by the protein complex eIF-4F,
through its eIF-4E subunit which binds speci¢cally to the 5P
cap structure of mRNAs. Binding of eIF-4E with speci¢c
proteins termed 4E-BPs has been shown to prevent the for-
mation of eIF-4F by sequestering eIF-4E and to impair cap-
dependent but not cap-independent translation under condi-
tions such as heat shock or virus infection [2^7]. The phos-
phorylation state of 4E-BPs plays an important role in the
regulation of eIF-4E availability [4^12] and increased phos-
phorylation of 4E-BP1 has been reported to cause its dissoci-
ation from eIF-4E and to stimulate protein synthesis in re-
sponse to insulin [5,13].
We have previously reported that impairment of the trans-
lation can at least partly explain the rapid inhibition of pro-
tein synthesis that occurs when isolated rat hepatocytes are
incubated under low oxygen pressure [19,20]. In the present
study, we demonstrate for the ¢rst time that hypoxia causes
the dephosphorylation of 4E-BP1 and stimulates its associa-
tion with the 5P mRNA cap-binding protein eIF-4E in these
cells. In Western blots performed on total cell extracts, three
isoforms of 4E-BP1 are present in hepatocytes incubated
under high pO2 (700 mm Hg O2). Consistent with other mod-
els [5,6,10^16] these electrophoretic forms of 4E-BP1 corre-
spond to di¡erent phosphorylation states, ranging from a
fast-migrating dephosphorylated band (K) to a slow-migrating
hyperphosphorylated band (Q). Compared to control hepato-
cytes, hypoxia modi¢es the electrophoretic pattern of 4E-BP1,
resulting in an increased amount of the K form that coincides
with the disappearance of the slow-migrating band. Since our
results show that exposure of hepatocytes to low oxygen pres-
sure causes the dephosphorylation of 4E-BP1, this might in-
£uence its ability to bind to eIF-4E. Consistent with this hy-
pothesis, we have found an enhanced amount of 4E-BP1
associated with eIF-4E in hepatocytes maintained under hy-
poxia and only the K and L forms were recovered after partial
puri¢cation of cell lysates with the m7GTP-Sepharose a⁄nity
resin that binds eIF-4E.
Rapamycin is an immunosuppressant that forms a complex
with the immunophilin FKBP12 to generate a potent inhibitor
of mTOR, a member of the phosphatidylinositol kinase-re-
lated kinases, that is an upstream activator of the ribosomal
S6 protein kinase (p70S6k) [2,3,27]. Observations that rapamy-
cin prevents the enhanced phosphorylation of 4E-BP1 induced
by numerous stimuli such as hormones and mitogens support
a role of mTOR in the signal transduction pathway that reg-
ulate 4E-BP1 phosphorylation [14,15,27^32]. The rapamycin-
sensitive events immediately upstream of 4E-BP1 and p70S6k
are distinct [30,31] and recent data indicate that mTOR itself
may be the physiological 4E-BP1 kinase [15]. Like hypoxia,
treatment of control hepatocytes with rapamycin induces the
dephosphorylation of 4E-BP1 and thereby increases the
amount of 4E-BP1 bound to eIF-4E. Since no additive e¡ect
was found when hypoxic hepatocytes were treated with rapa-
mycin, our results suggest that mTOR might be required for
the response to hypoxia. The mechanism by which hypoxia
causes the dephosphorylation of 4E-BP1 remains however to
be elucidated. It might involve either inhibition of mTOR,
which is believed to be the physiological kinase of 4E-BP1,
or activation of a phosphatase. Indeed, recent data suggest
that a mTOR-controlled downstream protein phosphatase
might be involved in the 4E-BP1 dephosphorylation induced
by amino acid withdrawal in Chinese hamster ovary cells
overexpressing human insulin receptors [8].
As 4E-BP1 competes with eIF-4G for binding eIF-4E [3,4],
the increased binding of 4E-BP1 to eIF-4E in response to
hypoxia is expected to prevent the formation of eIF-4F and
thereby to impair the cap-dependent mRNA translation. Our
results, however, indicate that sequestration of eIF-4E by 4E-
BP1 is not su⁄cient to explain the signi¢cant inhibition of
protein synthesis that occurs when cells are incubated under
low oxygen pressure. Indeed, whereas the e¡ects of rapamycin
and hypoxia on the 4E-BP1/eIF-4E complex were similar,
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Fig. 4. E¡ect of hypoxia and rapamycin on the synthesis of total
proteins. Cells were incubated for 90 min in DMEM under either
control (700 mm Hg O2 ; circles) or hypoxic (50 mm Hg O2 ;
squares) conditions in the absence (¢lled symbols) or presence (open
symbols) of rapamycin 500 nM. The synthesis of proteins was esti-
mated by measuring the incorporation of [14C]leucine into proteins
as described in Section 2. Results are means þ S.E.M. of three sepa-
rate experiments. Two-factor (time-treatment) ANOVA test was per-
formed. It showed a signi¢cant e¡ect (P6 0.05) of hypoxia as com-
pared to control aerobic conditions. No signi¢cant e¡ect was
observed for rapamycin as compared to either aerobic or hypoxic
conditions.
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rapamycin did not signi¢cantly decrease the incorporation of
[14C]leucine into proteins. Rapamycin has been reported to
inhibit the synthesis of myc but not actin in a myeloid pro-
genitor cell line [32] and to have a modest e¡ect on the rate of
total protein synthesis in several cell types, thus implying a
possible role of 4E-BP1 in the regulation of the translation of
speci¢c mRNAs rather than the overall rate of protein trans-
lation [10,12]. Another downstream element of mTOR is
p70S6k whose inhibition by rapamycin has been shown to
selectively impair the translation of mRNAs that contain an
oligopyrimidine tract at their transcriptional start [33]. Since
hypoxia but not rapamycin inhibits the synthesis of total pro-
teins, our results suggest that the downstream elements of the
mammalian target protein of rapamycin action, 4E-BP1 and
p70S6k, are unlikely to be involved in the impairment of the
overall mRNA translation despite our observation that hy-
poxia causes the dephosphorylation of 4E-BP1. The mecha-
nism by which hypoxia represses the overall rate of translation
in isolated hepatocytes is not de¢nitely established. Like tran-
sient cerebral ischemia in the rat or heat shock in various cell
types [1,2,10,34] it might involve changes in the phosphoryla-
tion states and the activities of eIF-2 and eIF-2B that mediate
the binding of the initiator methionyl-tRNA to the 40S ribo-
somal subunit, a step common to the translation of all
mRNAs. However, this hypothesis remains to be further in-
vestigated.
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